| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |